Join 30,000+ investors receiving these insights directly in your inbox.
4
min read
April 22, 2026
"Investing should be more like watching paint dry or watching grass grow." — Paul Samuelson
The instinct is to act. But activity isn't progress. The quieter it feels, the better it often works.

Iran continues restricting access through the Strait of Hormuz, a key route for roughly 20% of global oil supply. Fewer ships moving means less oil available, regardless of diplomacy.
Why it matters: This isn't just a geopolitical story — it's a supply bottleneck. When physical supply drops, inflation tends to follow quickly.
Assets in Focus: Commodities

US stocks moved higher after the Iran ceasefire was extended, with the S&P 500 up around 0.7% and the Nasdaq leading.
Why it matters: Markets often price direction, not headlines. Stability — even temporary — can lift risk assets quickly.
Assets in Focus: Equities

Strong results from GE Vernova, Boeing, and AT&T are helping stabilize sentiment. Demand tied to infrastructure and energy — especially data centers — is driving upside surprises.
Why it matters: Earnings are still the anchor. When profits hold up, markets tend to recover faster than expected.
Assets in Focus: Equities, Fixed Income

Investor enthusiasm for AI is accelerating again, with major firms doubling down on investment and valuations climbing. A new wave of innovation is pushing markets higher. The gap between "AI optimism" and real-world uncertainty is widening.
Why it matters: Innovation cycles can drive markets longer than expected — but also create pockets of overconfidence.
Assets in Focus: Equities

Asian markets were mixed, reflecting a tug-of-war between easing oil prices and ongoing geopolitical uncertainty. Investors are watching diplomacy closely while staying selective.
Why it matters: When markets move sideways globally, it often signals a transition phase — not a clear trend.
Assets in Focus: Equities
If oil, inflation, and rates all move together — are you diversified, or just exposed in different ways? Calculate my score

Some investors are paying $50,000–$100,000+ to clone their pets, backing companies turning this into a scalable business. The market is worth ~$4–5B today and projected to reach $8B+ by 2030. Biotech firms have raised $200M+ to expand cloning and explore "de-extinction" projects. It's about turning genetic identity itself into an asset people are willing to pay to preserve.
Diversification: A Practical Guide — History has repeatedly demonstrated its value, from the Great Depression to the 2008 financial crisis.
Put your money to work → PortfolioPilot.com
©2026 diversification.com. IMPORTANT DISCLOSURES: Global Predictions Inc, Registered Investment Advisor with the SEC. For informational and educational purposes only. Not financial advice. Investing involves risk.